CYP3A4

Jump to: navigation, search
Cytochrome P450, family 3, subfamily A, polypeptide 4
CYP3A4 PDB1W0E.png
Structure of CYP3A4 (from PDB 1W0E).
Heme group visible at center.
Identifiers
Symbol(s) CYP3A4; CYP3A; CP33; CP34; CYP3A3; HLP; MGC126680; NF-25; P450C3; P450PCN1
External IDs OMIM: 124010 Homologene88816
EC number 1.14.13.97
RNA expression pattern

PBB GE CYP3A4 205999 x at tn.png

PBB GE CYP3A4 205998 x at tn.png

PBB GE CYP3A4 208367 x at tn.png

More reference expression data

Orthologs
Human Mouse
Entrez 1576 na
Ensembl ENSG00000160868 na
Uniprot P05184 na
Refseq NM_017460 (mRNA)
NP_059488 (protein)
na (mRNA)
na (protein)
Location Chr 7: 99.08 - 99.22 Mb na
Pubmed search [1] na

WikiDoc Resources for

CYP3A4

Articles

Most recent articles on CYP3A4

Most cited articles on CYP3A4

Review articles on CYP3A4

Articles on CYP3A4 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CYP3A4

Images of CYP3A4

Photos of CYP3A4

Podcasts & MP3s on CYP3A4

Videos on CYP3A4

Evidence Based Medicine

Cochrane Collaboration on CYP3A4

Bandolier on CYP3A4

TRIP on CYP3A4

Clinical Trials

Ongoing Trials on CYP3A4 at Clinical Trials.gov

Trial results on CYP3A4

Clinical Trials on CYP3A4 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CYP3A4

NICE Guidance on CYP3A4

NHS PRODIGY Guidance

FDA on CYP3A4

CDC on CYP3A4

Books

Books on CYP3A4

News

CYP3A4 in the news

Be alerted to news on CYP3A4

News trends on CYP3A4

Commentary

Blogs on CYP3A4

Definitions

Definitions of CYP3A4

Patient Resources / Community

Patient resources on CYP3A4

Discussion groups on CYP3A4

Patient Handouts on CYP3A4

Directions to Hospitals Treating CYP3A4

Risk calculators and risk factors for CYP3A4

Healthcare Provider Resources

Symptoms of CYP3A4

Causes & Risk Factors for CYP3A4

Diagnostic studies for CYP3A4

Treatment of CYP3A4

Continuing Medical Education (CME)

CME Programs on CYP3A4

International

CYP3A4 en Espanol

CYP3A4 en Francais

Business

CYP3A4 in the Marketplace

Patents on CYP3A4

Experimental / Informatics

List of terms related to CYP3A4

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]


Overview

Cytochrome P450 3A4 (abbreviated CYP3A4) (EC 1.14.13.97), a member of the cytochrome P450 mixed-function oxidase system, is one of the most important enzymes involved in the metabolism of xenobiotics in the body. CYP3A4 is involved in the oxidation of the largest range of substrates of all the CYPs. CYP3A4 is also, correspondingly, present in the largest quantity of all the CYPs in the liver.

Fetuses do not express CYP3A4 in their liver/tissues; but rather CYP3A7, which acts on a similar range of substrates. CYP3A7 is gradually replaced by CYP3A4 in the developing neonate.

Distribution

Although CYP3A4 is predominantly found in the liver, it is also present in other organs and tissues of the body where it may play an important role in metabolism. CYP3A4 in the intestine plays an important role in the metabolism of certain drugs. Often this allows prodrugs to be activated and absorbed - as in the case of the histamine H1-receptor antagonist terfenadine.

Recently CYP3A4 has also been identified in the brain, however its role in the CNS is still unknown.[1]

Variability

While over 28 single nucleotide polymorphisms (SNPs) have been identified in the CYP3A4 gene, it has been found that this does not translate into significant interindividual variability in vivo. It can be supposed that this may be due to the induction of CYP3A4 on exposure to substrates.

Variability in CYP3A4 function can be determined noninvasively by the erythromycin breath test (ERMBT). The ERMBT estimates in vivo CYP3A4 activity by measuring the radiolabelled carbon dioxide exhaled after an intravenous dose of (14C-N-methyl)-erythromycin.[2]

Induction

CYP3A4 is induced by a wide variety of ligands. These ligands bind to the Pregnane X Receptor (PXR). The activated PXR complex forms a heterodimer with the Retinoid X Receptor (RXR) which binds to the XREM region of the CYP3A4 gene. XREM is a regulatory region of the CYP3A4 gene, and binding causes a cooperative interaction with proximal promoter regions of the gene, resulting in increased transcription and expression of CYP3A4.

CYP3A4 ligands

Selected inducers, inhibitors and substrates of CYP3A4[3]
Substrates Inhibitors Inducers
Often mentioned: [4]

Other:

Strong: [5]

unspecified:

Often mentioned: [4]

Other:

References

  1. Robertson G, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C (2003). "Transgenic mouse models of human CYP3A4 gene regulation". Mol Pharmacol 64 (1): 42-50. doi:10.1124/mol.64.1.42. PMID 12815159.
  2. Watkins P (1994). "Noninvasive tests of CYP3A enzymes". Pharmacogenetics 4 (4): 171-84. doi:10.1097/00008571-199408000-00001. PMID 7987401.
  3. Where classes of agents are listed, there may be exceptions within the class
  4. 4.0 4.1 Mentioned both in the reference named FASS and were previously mentioned in Wikipedia. Further contributions may follow other systems
  5. [http://www.fass.se/LIF/produktfakta/fakta_lakare_artikel.jsp?articleID=18352 Swedish environmental classification of pharmaceuticals] Facts for prescribers (Fakta för förskrivare)
  6. 6.0 6.1 Non-nucleoside reverse transcriptase inhibitors have been shown to both induce and inhibit CYP3A4.

Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages